Public market insider buying at VersaBank (VBNK)

VersaBank (VBNK) Senior Officer John William Asma acquired 4,000 common shares indirectly at $31.25 each on September 8, 2026, investing $125,000 and increasing his holdings by 33.3%.

Original reporting
Published Sep 14, 2026, 10:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 4:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Public market insider buying at VersaBank (VBNK) — source image
Decision brief

The 30-second read

Low
01

Why it matters

The disclosed insider purchase is small and unlikely to move the stock price materially.

02

Market read

Limited relevance; primarily of interest to insiders and very short‑term traders.

03

What to watch

Potential upcoming corporate actions or market conditions not disclosed.

Relevance 4/10Novelty 2/10Timing: September 8th, 2026

Background

VersaBank (VBNK) is a Canadian regional bank listed on the TSX.

Market effects

None significant for the banking sector.

Minimal impact on Canadian market.

None

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a confidence signal.

Key entities

  • John William Asma

    Senior Officer at VersaBank

Related articles

$VBNKMed

VersaBank (VBNK) Q3 2026 Earnings Call Transcript

VersaBank (VBNK) reported Q3 2026 earnings with total revenue of CAD 38.8 million, up 23% YoY, and net income of CAD 10.1 million, up 53% YoY. Growth was driven by the U.S. Structured Receivable Program (SRP), which contributed nearly 25% of digital banking revenue. Total assets reached CAD 7.2 billion, and the company aims for significant growth in FY 2027, including a target of US$3 billion in U.S. SRP fundings.

Med

VersaBank (VBNK) (Q3 2026) Earnings Call Highlights: Record Assets Surpass $7

VersaBank reported Q3 2026 earnings with record assets of $7.2 billion. Net interest margin decreased to 2.44%, and non-core costs totaled $4.6 million. The CET1 ratio fell to 11.5%. Management targets $3 billion in U.S. fundings for 2027, with half from existing partners. The AI-enabled real-time SRP program is driving demand. Divestiture of DRTC cybersecurity business extended to August 2027. Core noninterest expenses are expected to remain stable. The bank aims for 20% ROE at $10 billion in a

$VBNKMed

VersaBank (VBNK): Financial results for FY2027

VersaBank (VBNK) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 FOR IMMEDIATE RELEASE: September 3, 2026 VERSABANK REPORTS STRONG THIRD QUARTER RESULTS: ACCELERATING US SRP GROWTH DRIVES 23% YEAR-OVER-YEAR INCREASE IN REVENUE, 53% GROWTH IN NET INCOME AND 27% GROWTH IN ADJUSTED (CORE) NET INCOME AS IT CONTINUES TO BENEFIT FROM OP

$VBNKMed

VersaBank (NASDAQ:VBNK) Shares Down 6.6% – What’s Next?

VersaBank (NASDAQ:VBNK) shares fell 6.6% in mid-day trading Thursday, trading between $18.30 and $18.74 versus a prior close of $20.07. Volume was 47,027 shares, down 21% from average. Analysts cited mixed views: consensus target $13.00. The bank reported Q1 EPS of $0.27 and revenue of $26.80M, and declared a $0.025 quarterly dividend.